TRI-MIX 30/1/40 Injectable Recalled Due to Lack of Sterile Assurance
Carolina Infusion is recalling TRI-MIX 30/1/40 Injectable due to lack of assurance of sterility. Affected lots were distributed nationwide and pose risk of infection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is classified as FDA Class II and involves lack of sterile assurance on an injectable medication, which presents significant risk of serious infection. No illnesses or injuries have been reported to date, placing it at High severity per the rubric criterion for risk-of-harm products without reported injury.
Plain-English summary
Carolina Infusion is recalling TRI-MIX 30/1/40 Injectable, 10 mL vials, due to lack of assurance of sterility. The recall affects two specific lots distributed nationwide in the United States.
Non-sterile injectable medications pose a significant risk of infection to patients. If these products were administered and contaminated, patients could develop serious infections at injection sites or systemically.
The affected lots are: Lot 07052022@8 (expiration date 09/03/2022) and Lot 07292022@10 (expiration date 09/27/2022). Patients who have received injections from these lots should contact their healthcare provider immediately to report any signs of infection, including redness, warmth, swelling, or drainage at injection sites.
Healthcare providers should stop using these lots and properly dispose of any remaining product according to pharmaceutical waste protocols.
The recalled product
- Product
- TRI-MIX 30/1/40 Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
- Manufacturer
- Carolina Infusion
- Category
- Drug — Injectable / Sterility
- Hazard
- sterility-failure
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots: 07052022@8
- BUD: 09/03/2022
- 07292022@10
- BUD: 09/27/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01